English
中文简体
中文繁体
Company
Overview
Board of Directors
Partnering
Technology
Glycan-specific Conjugation
Alphatecan
Bispecific Antibody
Subcutaneous Formulation
Single-domain Antibody
Publications
Pipeline
Overview
Envafolimab(KN035)
KN026
JSKN003
JSKN016
JSKN033
KN046
KN019
Investors
Information Disclosure
Corporate Governance
Stock Information
Corporate Communications
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
Company
Overview
Board of Directors
Partnering
Technology
Glycan-specific Conjugation
Alphatecan
Bispecific Antibody
Subcutaneous Formulation
Single-domain Antibody
Publications
Pipeline
Overview
Envafolimab(KN035)
KN026
JSKN003
JSKN016
JSKN033
KN046
KN019
Investors
Information Disclosure
Corporate Governance
Stock Information
Corporate Communications
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
English
中文简体
中文繁体
Investors
Information Disclosure
Listing Documents
Financial Reports
Announcements & Circulars
Company Presentation
ESG Reports
Corporate Governance
Stock Information
Corporate Communications
Email Subscription
Announcements & Circulars
The announcement begins in December 2019
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 12, 2025
2025-06-12
INSIDE INFORMATION ANNOUNCEMENT - COMPLETION OF PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER
2025-06-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
2025-06-04
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES OF JSKN003 FOR PRESENTATION AT 2025 ASCO ANNUAL MEETING
2025-06-03
INSIDE INFORMATION ANNOUNCEMENT - PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER
2025-06-03
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
2025-05-29
Next Day Disclosure Return
2025-05-26
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 12, 2025
2025-05-20
NOTICE OF ANNUAL GENERAL MEETING
2025-05-20
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES (INCLUDING RESELL OR TRANSFER TREASURY SHARES); (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITORS; AND (4) NOTICE OF ANNUAL GENERAL MEETING
2025-05-20
1
2
3
4
PREV
1/28
NEXT